NivolumabHyponatraemia secondary to adrenal insufficiency and hypothyroidism: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1837卷 / 1期

关键词：

D O I：

10.1007/s40278-021-89123-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：524 / 524

相关论文

共 50 条

[1] NivolumabHyponatraemia and adrenal insufficiency: case report
[J]. Reactions Weekly, 2022, 1911 (1) : 334 - 334
[2] Ipilimumab/nivolumabHyponatraemia, hypophysitis and adrenal insufficiency: case report
[J]. Reactions Weekly, 2022, 1923 (1) : 270 - 270
[3] NivolumabHyponatraemia and adrenal failure secondary to adrenalitis: case report
[J]. Reactions Weekly, 2017, 1640 (1) : 276 - 276
[4] NivolumabHypophysitis, primary hypothyroidism and secondary adrenal insufficiency: case report
[J]. Reactions Weekly, 2018, 1714 (1) : 299 - 299
[5] Simultaneous Presentation of Secondary Adrenal Insufficiency and Primary Hypothyroidism due to Pembrolizumab: A Case Report
Khatri, Shivam
Alom, Mulham
Kashfi, Simon
Atallah, Jane
Goswami, Gayotri
[J]. JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
[6] PembrolizumabThyroiditis, adrenal insufficiency and primary hypothyroidism: case report
[J]. Reactions Weekly, 2018, 1726 (1) : 272 - 272
[7] PembrolizumabSecondary adrenal insufficiency and primary hypothyroidism: case report
[J]. Reactions Weekly, 2023, 1975 (1) : 308 - 308
[8] NivolumabHypophysitis, hypothyroidism and central adrenal insufficiency: case report
[J]. Reactions Weekly, 2019, 1770 (1) : 306 - 306
[9] Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report
[J]. Reactions Weekly, 2021, 1852 (1) : 247 - 247
[10] PembrolizumabHypophysitis with secondary adrenal insufficiency: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 427 - 427

← 1 2 3 4 5 →